Philips’ service model of PACS got a shot in the arm at the Healthcare Information and Management Systems Society conference with the unveiling today of advanced visualization tools that will bring 3D to any desktop on the client’s iSite network. The tools, presented as works-in-progress due for general release later this year, will provide multiplanar reformats, maximum intensity projection, and other volume visualization capabilities.
Philips' service model of PACS got a shot in the arm at the Healthcare Information and Management Systems Society conference with the unveiling today of advanced visualization tools that will bring 3D to any desktop on the client's iSite network. The tools, presented as works-in-progress due for general release later this year, will provide multiplanar reformats, maximum intensity projection, and other volume visualization capabilities.
With its acquisition two years ago of Stentor, Philips Medical Systems chose to enter the PACS arena using a service model. Stentor's rebranded and evolved iSite Enterprise operates for Philips clients on a pay-per-study basis. Its core technology, the iSyntax, enables on-demand, enterprise-wide delivery of images to standard PCs and workstations using existing information technology infrastructure.
What's been lacking has been access to 3D images through these desktop PCs. Philips' answer, which debuted today at HIMSS, is now being evaluated at clinical sites, according to Sybo Dijkstra, senior director of marketing for Philips healthcare informatics.
It will be generally available by the end of 2007, he said. When it is, these tools will leverage the company's iSyntax, delivering volumetrically reconstructed images to desktops within three seconds. The speed comes from the ability of iSyntax to navigate large data sets to find and download only the needed data when they are needed.
"We have taken the platform radiology PACS in iSite Enterprise and integrated our clinical value so that you don't need a separate parallel infrastructure or special attachment to the PACS," Dijkstra told DI SCAN.
Gone is the additional thin-client server that some vendors require to do advanced postprocessing, he said. No need for a dedicated 3D workstation either.
"In this, 3D comes as an advanced functionality to virtually all users who want to have access to it throughout the healthcare enterprise," he said.
Users of these tools will also find they have access to more than just volumetric reconstruction. The MIP and MPR functions are enhanced with links between the 3D images and 2D representations. Dijkstra describes these links as "much more advanced than the standard MIP/MPR functionality present in most PACS," a claim he and his colleagues plan to demonstrate the rest of this week on the HIMSS exhibit floor.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.